No therapeutic cancer vaccine had ever made it to the market here, despite numerous attempts.
So is a cancer vaccine from Oncothyreon and Merck KGaA, the German Merck.
Dendreon's (nasdaq: DNDN - news - people ) Provenge is a so-called cancer vaccine.
Scientists claim to have found new opportunities for a "cancer vaccine" to encourage attacks on cancer cells.
After that, the next product in the pipeline is Melacine, another cancer vaccine, which came with Ribi Immunochem.
Here are five key numbers that will help determine how fast Provenge, the first therapeutic cancer vaccine, sells.
Celldex shares cratered by 30% after Pfizer dumped its partnership to develop a new brain cancer vaccine.
FORBES: Setback For Personalized Medicine As Pfizer Drops Celldex Brain Drug
The brain cancer vaccine is one of the more intriguing targeted cancer treatments.
His tumor had a gene mutation being targeted by a new cancer vaccine being tested by Duke neurosurgeon John Sampson.
"Merck is proud to be the leader in cervical cancer vaccine research and development, " says Merck Chief Executive Richard T.
The new test would identify cells that over-expressed three genes Corixa discovered while trying to develop a breast cancer vaccine.
Basic conclusion: the data on the first-of-its-kind prostate cancer vaccine supports paying for it for a narrow group of patients.
Three years after the controversial Provenge prostate cancer vaccine was approved by the FDA, Dendreon has finally released a television ad campaign.
FORBES: Is The Dendreon TV Campaign For Provenge 'Too Little, Too Late?'
Yet another potential setback for Dendreon and its Provenge prostate cancer vaccine.
FORBES: Dendreon Takes Another Hit: This Time, Thanks To Johnson & Johnson
CDX-110 is not the only candidate for a brain cancer vaccine, either.
He points to two late stage lung cancer vaccine trials that could remove any remaining uncertainty about the potential future of cancer vaccines.
Among others, in 1995 it funded a young Johns Hopkins researcher to test a new concept for a prostate cancer vaccine on 20 patients.
Dendreon said today that it is planning to file an application with the Food and Drug Administration to have its cancer vaccine, Provenge, approved.
Mitchell may be one of the first to benefit from a new brain cancer vaccine, now in midstage testing at Pfizer and Avant Immunotherapeutics.
Provenge fans, who include many individual investors and some patients, often try to paint Provenge, the first therapeutic cancer vaccine, as the be-all-and-end-all of tumor-stopping.
GlaxoSmithKline is developing its own cervical cancer vaccine, Cervarix, which some studies show may be even better than Gardasil at teaching the immune system to fight off the virus.
By 2014, the top five bestselling drugs will all be biotech products, predicts veteran biotech financier Stelios Papadopoulos, who spoke at a recent MD Becker Partners cancer vaccine conference.
FORBES: Will Anyone Pay For The Next Generation of Stem Cell Cures?
He puts the cells in one of three dozen refrigerator-size incubators operating at 98.6 degrees, where they will grow into the main component of Lucanix, a cancer vaccine he developed.
Dendreon (nasdaq: DNDN - news - people ) said today that it is planning to file an application with the Food and Drug Administration to have its cancer vaccine, Provenge, approved.
The collaborators in both clinical trials include Dr. George Peoples, director of the Cancer Vaccine Development Laboratory and Deputy Director of the U.S. Military Cancer Institute, and Dr. Constantine Ioannides, former Professor of Immunology at the M.
FORBES: Roche Accelerates Defense Strategy to Protect Breast-Cancer Drug Herceptin's Turf
Apparently, experience doesn't count for everything: Aside from Gillis' problems with Bexxar, Henney is steering his current company, Dendreon (nasdaq: DNDN - news - people ), out of some recent disappointments over a prostate cancer vaccine.
Here are a few posts that you may have missed about the sales potential for the first cancer vaccine, why pharmaceutical giants are failing at their attempts to develop cancer drugs, and the race to market new pills to fight the hepatitis C virus.
应用推荐